Equity Profile

STVN

Stevanato Group S.p.A.

Health CareLife Sciences Tools & Services$5.9B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Stevanato Group S.p.A. is a healthcare company that specializes in producing glass vials and other packaging solutions for the pharmaceutical industry....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$0.15

Revenue

Revenue figures provide insight into the company's sales performance and market demand.

$298M

Wall Street expectations, options signals, track record, and call prep available with Pro.

STVN Q2-2026 Earnings Preview

Context

Company Snapshot

Stevanato Group S.p.A. is a healthcare company that specializes in producing glass vials and other packaging solutions for the pharmaceutical industry. With a market cap of $6 billion, it plays a crucial role in ensuring the safe delivery of medications, especially as demand for healthcare products continues to grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+4.93%

Avg Stock Reaction

+4.40%

Last Quarter Recap

In Q1-2026, Stevanato reported an EPS of $0.13, exceeding expectations by nearly 6%. However, the stock fell by over 5% the next day, indicating market caution despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Stevanato to report a modest earnings increase this quarter, with a consensus EPS of $0.15 and revenue of $298 million. The market is watching closely for any signs of growth or challenges in the healthcare sector.

Bull Case

If Stevanato can exceed EPS expectations and show strong revenue growth, it could signal robust demand for its products, potentially leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet earnings expectations or provides weak guidance, it could raise concerns about its growth prospects, leading to a negative market reaction.

Key Metrics to Watch

EPS

$0.15

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$298M

Revenue figures provide insight into the company's sales performance and market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $0.15?

A beat on EPS could indicate stronger profitability and boost investor confidence.

What is the revenue outlook for the next quarter?

Guidance on revenue will be crucial for assessing future growth potential and market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Stevanato's ability to capitalize on growing demand for pharmaceutical packaging solutions, especially as healthcare spending increases.

Supporting Evidence

The options market is pricing a 34.08% move, suggesting traders expect significant volatility, which may not align with historical performance.

Stevanato's recent earnings history shows a tendency to surprise on the upside, which could lead to a positive outcome this quarter.

Key Risk

If revenue comes in below $293 million, it could undermine the growth narrative and lead to a reevaluation of the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Stevanato can sustain its growth amid increasing competition and market pressures.

Bull Confirmed If

An EPS of $0.16 or higher would confirm strong profitability and positive market sentiment.

Bear Confirmed If

An EPS below $0.14 would raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±34.08%

Historical Avg

±8.7%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±34.1% while STVN has averaged ±8.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

36.1%

Calls (300)P/C Ratio: 0.11Puts (300)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stevanato beats expectations, history suggests a potential average one-day move of +1.1%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of around 13.55% based on historical patterns, indicating significant market disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships in the pharmaceutical sector.
2Management's commentary on supply chain challenges and how they are being addressed.
3Insights into demand trends for their packaging solutions.
4Guidance on future revenue growth and market expansion plans.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Stevanato Group S.p.A. is a healthcare company that specializes in producing glass vials and other packaging solutions for the pharmaceutical industry....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$0.15

Revenue

Revenue figures provide insight into the company's sales performance and market demand.

$298M

Wall Street expectations, options signals, track record, and call prep available with Pro.

STVN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+4.93%

Avg Stock Reaction

+4.40%

Last Quarter Recap

In Q1-2026, Stevanato reported an EPS of $0.13, exceeding expectations by nearly 6%. However, the stock fell by over 5% the next day, indicating market caution despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Stevanato can exceed EPS expectations and show strong revenue growth, it could signal robust demand for its products, potentially leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet earnings expectations or provides weak guidance, it could raise concerns about its growth prospects, leading to a negative market reaction.

Key Metrics to Watch

EPS

$0.15

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$298M

Revenue figures provide insight into the company's sales performance and market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $0.15?

A beat on EPS could indicate stronger profitability and boost investor confidence.

What is the revenue outlook for the next quarter?

Guidance on revenue will be crucial for assessing future growth potential and market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Stevanato's ability to capitalize on growing demand for pharmaceutical packaging solutions, especially as healthcare spending increases.

Supporting Evidence

The options market is pricing a 34.08% move, suggesting traders expect significant volatility, which may not align with historical performance.

Stevanato's recent earnings history shows a tendency to surprise on the upside, which could lead to a positive outcome this quarter.

Key Risk

If revenue comes in below $293 million, it could undermine the growth narrative and lead to a reevaluation of the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Stevanato can sustain its growth amid increasing competition and market pressures.

Bull Confirmed If

An EPS of $0.16 or higher would confirm strong profitability and positive market sentiment.

Bear Confirmed If

An EPS below $0.14 would raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±34.08%

Historical Avg

±8.7%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±34.1% while STVN has averaged ±8.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

36.1%

Calls (300)P/C Ratio: 0.11Puts (300)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stevanato beats expectations, history suggests a potential average one-day move of +1.1%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of around 13.55% based on historical patterns, indicating significant market disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships in the pharmaceutical sector.
2Management's commentary on supply chain challenges and how they are being addressed.
3Insights into demand trends for their packaging solutions.
4Guidance on future revenue growth and market expansion plans.